Terms ending in 2026
Every in-force patent on Bayer AG's record whose computed term ends in 2026, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,173,037 | Carbamate-Substituted Pyrazolopyridines In force · High confidence | Adverio Pharma GmbH | In force | High confidence | |
| US 7,534,397 | Sample Preparation Device In force · High confidence | Siemens Healthcare Diagnostics Inc. | In force | High confidence | |
| US 7,475,701 | Valve Systems and Injector System Including Such Valve Systems In force · High confidence | Bayer Healthcare LLC | In force | High confidence | |
| US 7,612,925 | Double-Side Image Scanner and Scanning Method of the Same In force · High confidence | Intellectual Ventures I LLC | In force | High confidence | |
| US 8,097,603 | Compositions for Controlling Parasites on Animals In force · High confidence | Elanco Animal Health GmbH | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Bayer AG.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.